Aug 31, 2012 - 7:19 pm
Got results of my Chest, abdomen, and pelvis scans today (all without contrast). My first scan was 3 months ago and surgery almost 8 weeks ago. My oncologist said he ordered these as a post-surgery baseline.
I'm looking for opinions on a few things. A couple of these are for MedScanMan and the rest to everyone that wishes to contribute.
There were a couple of incidental findings on my report that I'm not really worried about because I googled them and they don't sound important. But, what I'm wondering is, if these were on the prior scan, why would the radiologist not mention them? Is it likely he overlooked them or does the radiologist not look in detail at areas that are not related to the doctor's stated reason for the scan? The scan where my tumor was discovered was for GI problems. Or should I assume these are new developments? Or none-of-the-above?
To anyone who would like to contribute:
I asked my Oncologist whether my future scans would be with contrast. He said "That's a good question. There is always a concern about the one kidney. We can see how your bloodwork looks then and discuss it. I may alternate." My next scan will be in December. My creatinine is currenly 1.6. I'm looking for advice on how to weigh the risk against the benefit. I assume that a scan without contrast could miss some small mets or is that wrong? I remember that the PA at my Urologist's office said it wasn't important to find mets when they are tiny because they don't treat mets until they reach a certain size anyway (don't remember the size. She just demonstrated with the tip of her finder). After the December scan, I go to every 6 months. If he alternates the use of contrast each time, I think it means I could walk around with mets for almost a year before they are discovered. I'm just wondering how I will decide whether to lobby for or against contrast. As a reminder, although my tumor was only stage 2, it was Grade 4 unclassified renal cell carcinoma with 30-40% necrosis which all indicate it was a very aggressive tumor.